NovaGo Therapeutics: Funding, Investors & Team (Oct 2026)
NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke,
NovaGo Therapeutics has raised $29.7M across 1 funding round on record, the most recent a Series B of $29.7M announced in Aug 2026.
That round is below the $47M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NovaGo Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
NovaGo Therapeutics Funding Rounds
NovaGo Therapeutics Investors
NovaGo Therapeutics Founders and Leadership Team
Contact details for the NovaGo Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →NovaGo Therapeutics Funding Compared to Other Biotechnology Startups
NovaGo Therapeutics' latest round of $29.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NovaGo Therapeutics in Biotechnology and Schlieren
Companies Similar to NovaGo Therapeutics
Boulevard Bio is a biotechnology company founded by Deerfield Management that develops novel therapies for…
Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine.
Syngenis Labs is committed to helping businesses and research organizations with their diagnostic and…
SensorX Solutions operates as a manufacturer of IoT sensors.
One interface for every open source model
Food Founders Studio is a venture studio that builds and launches B2B food tech ventures.
Terra Preta is a platform for decentralized biochar production that removes carbon and restores soil health.
Bee People taps into the ingenuity of bees to produce natural health supplements and superfoods.
Prevision Medicine AG is a oncology company that provides cancer therapy, tests living cancer cells, and…
smartNsales is the AI workspace for FMCG teams, connecting key accounts, activations, trade investment,…
ETFbook is a platform that specializes in providing information and analysis on exchange-traded funds (ETFs).…
Embodied AI develops robotic manipulators and AI models for human-robot interaction.
NovaGo Therapeutics Funding FAQs
What does NovaGo Therapeutics do?
NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke,
How much funding has NovaGo Therapeutics raised?
NovaGo Therapeutics has raised $29.7M across 1 round on record. The most recent is a Series B of $29.7M announced in Aug 2026.
When did NovaGo Therapeutics last raise funding?
NovaGo Therapeutics' most recent funding round on record is a Series B of $29.7M, announced in Aug 2026.
Who has invested in NovaGo Therapeutics?
Investors on record for NovaGo Therapeutics include Swiss Paraplegic Foundation, Neurimmune Holding, Pureos Bioventures, Kinled Holding, Wings for Life.
Where is NovaGo Therapeutics headquartered?
NovaGo Therapeutics is based in Schlieren, Switzerland.
How many employees does NovaGo Therapeutics have?
NovaGo Therapeutics is in the 1-10 employee band.
When was NovaGo Therapeutics founded?
NovaGo Therapeutics was founded in 2015.
How does NovaGo Therapeutics' funding compare to other Biotechnology startups?
NovaGo Therapeutics' latest round of $29.7M is below the $47M median round size for Biotechnology companies on FundedIQ across 5 tracked companies over the last two years.
About FundedIQ's NovaGo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NovaGo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.